22-23833655-C-T
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM1PM2PM5PP3_ModeratePP5_Very_Strong
The NM_003073.5(SMARCB1):c.1070C>T(p.Thr357Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T357R) has been classified as Likely pathogenic.
Frequency
Consequence
NM_003073.5 missense
Scores
Clinical Significance
Conservation
Publications
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- intellectual disability, autosomal dominant 15Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- rhabdoid tumor predisposition syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
- SMARCB1-related schwannomatosisInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics
- familial multiple meningiomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- schwannomatosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- complex neurodevelopmental disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SMARCB1 | NM_003073.5 | c.1070C>T | p.Thr357Ile | missense_variant | Exon 8 of 9 | ENST00000644036.2 | NP_003064.2 | |
| SMARCB1 | NM_001362877.2 | c.1124C>T | p.Thr375Ile | missense_variant | Exon 8 of 9 | NP_001349806.1 | ||
| SMARCB1 | NM_001317946.2 | c.1097C>T | p.Thr366Ile | missense_variant | Exon 8 of 9 | NP_001304875.1 | ||
| SMARCB1 | NM_001007468.3 | c.1043C>T | p.Thr348Ile | missense_variant | Exon 8 of 9 | NP_001007469.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:2
This sequence change replaces threonine with isoleucine at codon 357 of the SMARCB1 protein (p.Thr357Ile). The threonine residue is highly conserved and there is a moderate physicochemical difference between threonine and isoleucine. This variant is not present in population databases (ExAC no frequency). This variant has been observed to be de novo in an individual affected with Coffin-Siris syndrome (Invitae). Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at